Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

Contract Notice

COVID Related Sample Collection Service

  • First published: 17 August 2020
  • Last modified: 17 August 2020
  • This file may not be fully accessible.

  •  

Information icon

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Information icon
You are viewing an expired notice.

Contents

Summary

OCID:
Published by:
Genomics England Limited
Authority ID:
AA23344
Publication date:
17 August 2020
Deadline date:
28 August 2020
Notice type:
Contract Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

The COVID-19 human genome sequencing programme will recruit 20,000 people currently or previously in an intensive care unit with coronavirus, as well as 15,000 individuals who have mild or no symptoms during infection. The study aims to understand the genetic factors that influence risk of severe COVID-19. It has been designated as an urgent public health study by the NIHR and is jointly funded by the Department of Health and Social Care, UKRI and NIHR.

Genomics England Limited (GEL) is required to collect 15,000 genomic samples from volunteers who have suffered mild or asymptomatic COVID symptoms to provide a control cohort in support of COVID genomic research. GEL does not have integral sample collection capability, and support from NIHR research nurses and NHS Trusts to collect samples is not guaranteed, nor are they able to support home visits, the preferred collection method. This Contract Notice is to select a provider for the remaining 10,000+ samples to work with GEL from around October 2020 onwards.

Severe Retrospective Cases. Current severe retrospective recruitment numbers indicate that up to 70 % of volunteers will request a home visit for their sample collection. As a result, the samples that the collection provider will be required to collect will include both mild, and severe retrospective. The numbers of severe cases will be over and above the 10,000 mild samples but are not currently determined.

Additional Co-recruitment – (not yet confirmed). There is the possibility that the collection provider will also be asked to perform additional sample collection in certain instances. This would result in a 6-8 week period during which the majority, if not all, cases up to a volume of approximately 10,000 would require blood collection that includes the standard collection for the mild samples and other collection services during the same appointment.

Full notice text

Contract notice

Section I: Contracting authority

I.1) Name and addresses

Genomics England Limited

Dawson Hall, Charterhouse Square

London

EC1M 6BQ

UK

Telephone: +44 2078825030

E-mail: paul.nicholson@genomicsengland.co.uk

NUTS: UK

Internet address(es)

Main address: www.genomicsengland.co.uk

I.3) Communication

The procurement documents are available for unrestricted and full direct access, free of charge at:

https://genomicsengland.bravosolution.co.uk


Additional information can be obtained from the abovementioned address


Tenders or requests to participate must be sent electronically to:

https://genomicsengland.bravosolution.co.uk


Tenders or requests to participate must be sent to the abovementioned address


I.4) Type of the contracting authority

Body governed by public law

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

COVID Related Sample Collection Service

Reference number: GeL-COV-159-20

II.1.2) Main CPV code

79624000

 

II.1.3) Type of contract

Services

II.1.4) Short description

The COVID-19 human genome sequencing programme will recruit 20,000 people currently or previously in an intensive care unit with coronavirus, as well as 15,000 individuals who have mild or no symptoms during infection.

Genomics England Limited (GEL) is required to collect 15,000 genomic samples from volunteers who have suffered COVID symptoms to provide a control cohort in support of COVID genomic research. This Contract Notice aim is to select a provider for at least 10,000 mild samples and additional severe samples and other co-recruitment samples. Numbers of these severe samples and co-recruitment samples are not currently known with requirements being developed through 2020.

II.1.6) Information about lots

This contract is divided into lots: No

II.2) Description

II.2.2) Additional CPV code(s)

79624000

79625000

II.2.3) Place of performance

NUTS code:

UK


Main site or place of performance:

Nationwide

II.2.4) Description of the procurement

The COVID-19 human genome sequencing programme will recruit 20,000 people currently or previously in an intensive care unit with coronavirus, as well as 15,000 individuals who have mild or no symptoms during infection. The study aims to understand the genetic factors that influence risk of severe COVID-19. It has been designated as an urgent public health study by the NIHR and is jointly funded by the Department of Health and Social Care, UKRI and NIHR.

Genomics England Limited (GEL) is required to collect 15,000 genomic samples from volunteers who have suffered mild or asymptomatic COVID symptoms to provide a control cohort in support of COVID genomic research. GEL does not have integral sample collection capability, and support from NIHR research nurses and NHS Trusts to collect samples is not guaranteed, nor are they able to support home visits, the preferred collection method. This Contract Notice is to select a provider for the remaining 10,000+ samples to work with GEL from around October 2020 onwards.

Severe Retrospective Cases. Current severe retrospective recruitment numbers indicate that up to 70 % of volunteers will request a home visit for their sample collection. As a result, the samples that the collection provider will be required to collect will include both mild, and severe retrospective. The numbers of severe cases will be over and above the 10,000 mild samples but are not currently determined.

Additional Co-recruitment – (not yet confirmed). There is the possibility that the collection provider will also be asked to perform additional sample collection in certain instances. This would result in a 6-8 week period during which the majority, if not all, cases up to a volume of approximately 10,000 would require blood collection that includes the standard collection for the mild samples and other collection services during the same appointment.

II.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 12

This contract is subject to renewal: Yes

Description of renewals:

12 month extension option

II.2.9) Information about the limits on the number of candidates to be invited

II.2.10) Information about variants

Variants will be accepted: No

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Section III: Legal, economic, financial and technical information

III.1) Conditions for participation

III.1.2) Economic and financial standing

Selection criteria as stated in the procurement documents


III.1.3) Technical and professional ability

Selection criteria as stated in the procurement documents


III.2) Conditions related to the contract

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Open procedure

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

IV.2) Administrative information

IV.2.2) Time limit for receipt of tenders or requests to participate

Date: 28/08/2020

Local time: 12:00

IV.2.4) Languages in which tenders or requests to participate may be submitted

EN

IV.2.6) Minimum time frame during which the tenderer must maintain the tender

Tender must be valid until: 30/10/2020

IV.2.7) Conditions for opening of tenders

Date: 28/08/2020

Local time: 12:00

Section VI: Complementary information

VI.1) Information about recurrence

This is a recurrent procurement: No

VI.2) Information about electronic workflows

Electronic invoicing will be accepted

Electronic payment will be used

VI.3) Additional information

NB: The services required have been deemed to fall under the list of Services covered by the Light-Touch Regime under Schedule 3 of the Public Contracts Regulations 2015 and as such the procurement procedure reflects the necessary timescales required to meet the project requirements.

The procurement procedure meets the requirements of a light touch regime procurement and is reasonable in terms of approach and timings. Mandatory and discretionary exclusions apply and will be assessed as pass/fail requirements as part of tenderer' submissions following the exclusions set out within the standard selection questionnaire. Evaluation will be conducted against set criteria and decisions based on best price quality ratio (BPQR) to determine the successful service provider.

VI.4) Procedures for review

VI.4.1) Review body

High Court

London

UK

VI.5) Date of dispatch of this notice

10/08/2020

Coding

Commodity categories

ID Title Parent category
79625000 Supply services of medical personnel Supply services of personnel including temporary staff
79624000 Supply services of nursing personnel Supply services of personnel including temporary staff

Delivery locations

ID Description
100 UK - All

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

About the buyer

Main contact:
paul.nicholson@genomicsengland.co.uk
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.